Drug elimination study in healthy men
Part of Mental health clinical trials.
This study gives healthy men a single dose of a drug with a tiny amount of radioactivity to see how it leaves the body through urine and stool. It helps researchers understand how the drug is processed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy male adult.
- Your body mass index (BMI) is between 18.0 and 32.0.
- You have regular bowel movements (at least one per day) for the last 30 days.
- You have no history of heart problems like irregular heartbeat or heart failure.
- You are not currently taking any other experimental drugs or have taken one recently.
- You can stay in a stable living situation before and after the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication called SEP-363856 over a long period for people with schizophrenia who are currently stable. It looks at how well the drug works and its safety over time.
This is an early-stage study testing a new experimental drug called KR23248 in healthy volunteers to see if it is safe and how the body processes it. Researchers want to understand potential side effects and how the drug moves through your system.
This trial tests a new medication called SEP-363856 for people with schizophrenia who are currently having a severe flare-up of symptoms. It aims to see if the drug is safe and effective compared to a placebo.
This study uses brain scans (PET and MRI) to see how a specific receptor, called D3, is affected by antipsychotic medications in people with schizophrenia. You may be able to participate if you have not taken antipsychotics for at least 3 weeks and are not using nicotine products.
This study looks at how a drug called HS-10504 is processed and eliminated from the body. Healthy male volunteers take one dose so researchers can track where the drug goes. It helps determine the right dosing and safety for future patients.
This trial tests a new medication called SEP-479 in healthy volunteers to see how the body handles it. Volunteers receive either a single dose or multiple doses of the drug as part of early safety research.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.